Pulsair tonometer offers good reliability
The Pulsair EasyEye non-contact tonometer (Keeler) can be considered an accurate and reliable method of measuring intraocular pressure (IOP) in the normotensive population but it cannot be used interchangeably with the Goldmann tonometer.
The Pulsair EasyEye non-contact tonometer (Keeler) can be considered an accurate and reliable method of measuring intraocular pressure (IOP) in the normotensive population but it cannot be used interchangeably with the Goldmann tonometer, according to a report published in the January issue of Optometry & Vision Science.
Kelechi Ogbuehi and Turki Almubrad from the College of Applied Medical Sciences, Riyadh, Saudi Arabia conducted a masked, prospective study which included 72 right eyes of 72 subjects. Two sets of IOP measurements were taken one week apart, Goldmann measurements always being taken second after Pulsair measurements. Each method was assessed for within-session and test-retest repeatability and both methods were assessed for limits of agreement, twice.
The researchers found that both methods were repeatable within-sessions to within ±2 mmHg and between sessions within ±3 mmHg. Neither the within-session differences nor the between-session differences differed significantly between the two tonometers. The mean differences between both methods were not statistically significant but the IOP measured with Pulsair was consistently higher than that measured with the Goldmann tonometer.
It was concluded that the Pulsair is a reliable measurement tool but that it should not be used interchangeably with the Goldmann tonometer.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.
